A platform from 2460 Health TechVisit 2460.life
The Briefing

Meira Briefing

Week of July 13, 2026

Vol. 1 · Issue 7

Here's what happened this week.

1

CMS drops its CY2027 outpatient and ASC proposed rule with new payment factors, prior authorization expansion, and EMTALA compliance changes.

On July 7, CMS published its proposed rule revising the Hospital Outpatient (OPPS) and Ambulatory Surgical Center payment systems for calendar year 2027. It also expands prior authorization to additional Botulinum Toxin services, implements Consolidated Appropriations Act provisions for off-campus outpatient departments, and proposes that accrediting organizations assess certain EMTALA requirements during surveys. CMS is also soliciting comments on separate IPPS payment for domestic PPE and essential medicines procurement.
On your shift: Payment and EMTALA compliance shifts change how donor hospitals staff, schedule, and prioritize OR time, which is exactly where your case logistics live or die. The comment window is open now, so if OR access or hospital cooperation is a recurring friction point for you, this is where your OPO can weigh in.

Source: Federal Register - CMS Rules

2

New study scrutinizes the statistical behavior of the 2020 CMS OPO rank-order and tiering metric.

Published in the August issue, this analysis examines how the rank-order and tiering system from the 2020 CMS OPO Final Rule actually behaves statistically. The work matters because that metric determines which OPOs are certified, recertified, or decertified based on donation and transplant rates.
On your shift: The tiering metric is the scoreboard your organization is measured against, and questions about its statistical fairness feed directly into decertification anxiety and how leadership sets your case targets. Understanding whether the math holds up gives you context for the performance pressure landing on your shifts.

Source: PubMed (Organ Donation Research)

3

Ethical analysis published on time-limited trials in critical care.

This July 8 paper examines the ethics of time-limited trials, the practice of agreeing to a defined window of aggressive treatment before reassessing goals of care. It is a framework that shapes when and how end-of-life conversations move forward in the ICU.
On your shift: Time-limited trials directly affect the timing of when a patient reaches the point where donation becomes a conversation, and that timing drives your referral and family approach windows. Knowing the ethical framing helps you meet families and ICU teams where they are during those slow, difficult days.

Source: PubMed (Organ Donation Research)

2026 OPO Final Rule Compliance
Deadline for OPOs to meet updated CMS performance standards
117 days
OPO Recertification Cycle
2026 performance metrics enforcement deadline
117 days